:: Volume 7, Issue 1 (3-2021) ::
RABMS 2021, 7(1): 26-30 Back to browse issues page
COVID-19 in a Patient with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL): A Case Report
Alireza Gandomi-Mohammadabadi , Farshad Divsalar, Saman Taram, Zahra Kateb, Fatemeh Montazer, Yasaman Farbod, Seyedamir Tabibzadeh dezfooli, Ata Abbasi, Mohammad Amin Abbasi
Firoozabadi Clinical Research Development Unit (FCRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran. , Amin.abbasi1314@gmail.com
Abstract:   (637 Views)
Chronic lymphocytic leukemia (CLL) is one of the most common hematologic neoplasms leading to immunosuppression. It is characterized by absolute lymphocytosis with clonality of mature B cells. Therefore, they are vulnerable to various infections especially COVID-19. Little is known about the COVID-19 infection when it unmasks CLL.
We reported a 90-year-old man who presented with signs and symptoms of anorexia, weakness, and loss of consciousness, and lymphocytosis which in further workup COVID-19 confirmed with real-time PCR. Due to lymphocytosis, peripheral blood smear (PBS) and flow cytometry were performed and CLL was diagnosed. His lymphocyte count increased to 1.5-fold during hospitalization. The patient recovered after 11 days as the symptoms were alleviated.
Lymphocytosis is an unexpected finding in patients diagnosed with COVID-19 infection, and an increase in lymphocytes may indicate other conditions. In these cases, secondary causes of lymphocytosis, such as malignancy or other infections, should be considered
Keywords: Coronavirus, COVID-19, Leukemia, Lymphocytic, Chronic
Full-Text [PDF 720 kb]   (300 Downloads)    
Type of Study: case report | Subject: Special

XML   Persian Abstract   Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 1 (3-2021) Back to browse issues page